News & Updates
Filter by Specialty:
Bulevirtide boasts high barrier to resistance for chronic hepatitis delta
A recent study has found no amino acid substitutions associated with reduced sensitivity to bulevirtide (BLV) monotherapy, a hepatitis D/B virus (HDV/HBV) entry inhibitor, at baseline or week 24 in patients with virologic breakthrough after BLV treatment.
Bulevirtide boasts high barrier to resistance for chronic hepatitis delta
13 Sep 2023
Noninvasive MRE accurately stages liver fibrosis in NAFLD
Magnetic resonance elastography demonstrates high accuracy in the noninvasive staging of liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD), reports a study.
Noninvasive MRE accurately stages liver fibrosis in NAFLD
13 Sep 2023
Wine intake inversely tied to CV outcomes
A systematic review and meta-analysis showed an inverse relationship between wine consumption and the risks of cardiovascular (CV) mortality, CV disease (CVD), and coronary heart disease (CHD).
Wine intake inversely tied to CV outcomes
13 Sep 2023
SHBG levels inversely linked to hypertension in middle-aged adults
Levels of sex hormone-binding globulin (SHBG) show an inverse relationship with the development of hypertension and change in blood pressure (BP) levels, independent of major risk factors, according to a community-based study.
SHBG levels inversely linked to hypertension in middle-aged adults
12 Sep 2023
Which factors predict sustained RA remission with MTX or ETN monotherapy?
Following the switch from combination therapy to monotherapy, rheumatoid arthritis (RA) patients with overall lower disease activity (LDA) have higher odds of achieving and remaining in Simplified Disease Activity Index (SDAI) remission/LDA, suggests a study.
